These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31393011)

  • 1. Pregnant women with confirmed neoplasms should not have noninvasive prenatal testing.
    Lenaerts L; Van Calsteren K; Che H; Vermeesch JR; Amant F
    Prenat Diagn; 2019 Nov; 39(12):1162-1165. PubMed ID: 31393011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive prenatal testing: from aneuploidy to single genes.
    Guseh SH
    Hum Genet; 2020 Sep; 139(9):1141-1148. PubMed ID: 31555907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing.
    Amant F; Verheecke M; Wlodarska I; Dehaspe L; Brady P; Brison N; Van Den Bogaert K; Dierickx D; Vandecaveye V; Tousseyn T; Moerman P; Vanderstichele A; Vergote I; Neven P; Berteloot P; Putseys K; Danneels L; Vandenberghe P; Legius E; Vermeesch JR
    JAMA Oncol; 2015 Sep; 1(6):814-9. PubMed ID: 26355862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonreportable rates and cell-free DNA profiles in noninvasive prenatal testing among women with heparin treatment.
    Nakamura N; Sasaki A; Mikami M; Nishiyama M; Akaishi R; Wada S; Ozawa N; Sago H
    Prenat Diagn; 2020 Jun; 40(7):838-845. PubMed ID: 32274797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Most noninvasive prenatal screens failing due to inadequate fetal cell free DNA are negative for trisomy when repeated.
    Lopes JL; Lopes GS; Enninga EAL; Kearney HM; Hoppman NL; Rowsey RA
    Prenat Diagn; 2020 Jun; 40(7):831-837. PubMed ID: 32274800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequencing of Circulating Cell-free DNA during Pregnancy.
    Bianchi DW; Chiu RWK
    N Engl J Med; 2018 Aug; 379(5):464-473. PubMed ID: 30067923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causes of aberrant non-invasive prenatal testing for aneuploidy: A systematic review.
    Samura O; Okamoto A
    Taiwan J Obstet Gynecol; 2020 Jan; 59(1):16-20. PubMed ID: 32039788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between Z score, fetal fraction, and sequencing reads in non-invasive prenatal testing.
    Balslev-Harder M; Richter SR; Kjaergaard S; Johansen P
    Prenat Diagn; 2017 Sep; 37(9):943-945. PubMed ID: 28726258
    [No Abstract]   [Full Text] [Related]  

  • 9. Prenatal testing can detect occult cancer in pregnant women.
    Tanday S
    Lancet Oncol; 2015 Aug; 16(8):e383. PubMed ID: 26190750
    [No Abstract]   [Full Text] [Related]  

  • 10. Incidental Detection of Maternal Neoplasia in Noninvasive Prenatal Testing.
    Dharajiya NG; Grosu DS; Farkas DH; McCullough RM; Almasri E; Sun Y; Kim SK; Jensen TJ; Saldivar JS; Topol EJ; van den Boom D; Ehrich M
    Clin Chem; 2018 Feb; 64(2):329-335. PubMed ID: 28982650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High positive predictive value 22q11.2 microdeletion screening by prenatal cell-free DNA testing that incorporates fetal fraction amplification.
    Hammer C; Pierson S; Acevedo A; Goldberg J; Westover T; Chawla D; Mabey B; Muzzey D; Johansen Taber K
    Prenat Diagn; 2024 Jul; 44(8):925-935. PubMed ID: 38622914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Utterly unanticipated findings].
    Jordan B
    Med Sci (Paris); 2015 May; 31(5):567-8. PubMed ID: 26059309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive Prenatal Diagnosis of Single-Gene Disorders by Use of Droplet Digital PCR.
    Camunas-Soler J; Lee H; Hudgins L; Hintz SR; Blumenfeld YJ; El-Sayed YY; Quake SR
    Clin Chem; 2018 Feb; 64(2):336-345. PubMed ID: 29097507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-free DNA screening for fetal aneuploidy using the rolling circle method: A step towards non invasive prenatal testing simplification.
    Pavanello E; Sciarrone A; Guaraldo V; Muccinelli E; Ciuffreda VP; Sauro P; Bondielli G; Mirante S; Mengozzi G; Viora E; Cuckle H; Pasini B
    Prenat Diagn; 2021 Dec; 41(13):1694-1700. PubMed ID: 34569636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Setup and Application of Reference Material in Sequencing-Based Noninvasive Prenatal Testing.
    Qu S; Zhang Y; Yang X; Tan Y; Li M; Yang X; Zhou L; Chen D; Chen Y; Yan M; Wang Q; Yu T; Sun N; Jiang H; Su F; Di Y; Lin G; Yuan Y; Chen F; Mu F; Huang J
    Gynecol Obstet Invest; 2021; 86(1-2):123-131. PubMed ID: 33784691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics Pipeline for Accurate Quantification of Fetal DNA Fraction in Maternal Plasma.
    Ni M; Peng XL; Jiang P
    Methods Mol Biol; 2019; 1909():177-180. PubMed ID: 30580431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate of no result in cell-free DNA testing and its influence on test performance metrics.
    Grati FR; Kagan KO
    Ultrasound Obstet Gynecol; 2017 Jul; 50(1):134-137. PubMed ID: 27731527
    [No Abstract]   [Full Text] [Related]  

  • 18. The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation.
    Cai YH; Yao GY; Chen LJ; Gan HY; Ye CS; Yang XX
    DNA Cell Biol; 2018 Jul; 37(7):626-633. PubMed ID: 29957029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal chromosome Xp deletion identified by prenatal cell-free DNA screening.
    Ilagan BJ; Maxwell MD; Fisher BM; Milanovich J; Owen R; Anderson B; Zhang K; Strom CM
    Prenat Diagn; 2017 Sep; 37(9):935-937. PubMed ID: 28654736
    [No Abstract]   [Full Text] [Related]  

  • 20. Noninvasive Prenatal Test Results Indicative of Maternal Malignancies: A Nationwide Genetic and Clinical Follow-Up Study.
    Adams ED
    J Obstet Gynecol Neonatal Nurs; 2024 Jul; 53(4):320-323. PubMed ID: 38838740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.